Gene expression

“The OTTA-SPOT (Ovarian Tumor Tissue Analysis consortium – Stratified Prognosis of Ovarian Tumours) gene expression signature may improve risk stratification in clinical trials by identifying patients who are least likely to achieve 5-year survival. The identified novel genes associated with the outcome may also yield opportunities for the development of targeted therapeutic approaches.”    MORE

Image Credit:  yourgenome.org